Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19



Rating:

Share or cite this content

Citations should be made in the following way:
I. Andrievskaya (Blagoveshchensk, Russian Federation), I. Zhukovets (Blagoveshchensk, Russian Federation), N. Smirnova (Blagoveshchensk, Russian Federation), O. Demura (Blagoveshchensk, Russian Federation), A. Abuldinov (Blagoveshchensk, Russian Federation), K. Lyazgian (Blagoveshchensk, Russian Federation), V. Kolosov (Blagoveshchensk, Russian Federation). The clinical course of community-acquired pneumonia caused by SARS-COV-2 in pregnant women. 287

Member's Comments

No comment yet.

Related content which might interest you: Differential clinical and etiological features in young and elderly patients hospitalized due to community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002 The tobacco-smoking influence on the community-acquired pneumonia course Source: Eur Respir J 2006; 28: Suppl. 50, 247s Year: 2006 Etiology and clinical outcome of community-acquired pneumonias in hospitalized children Source: Eur Respir J 2007; 30: Suppl. 51, 398s Year: 2007 Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Community-acquired pneumonia in COVID-19 positive children: monitoring the clinical course Source: Virtual Congress 2021 – Acute paediatric respiratory infections Year: 2021 The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Effect of corticoids on the clinical course and outcome of severe community-acquired pneumonia Source: Annual Congress 2004 - SARS and other lower respiratory tract infections Year: 2004 Etiology of community-acquired pneumonia (CAP) in young hospital patients Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002 Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Microbiological study of community acquired pneumonia versus nosocomial pneumonia in pediatric age group Source: Eur Respir J 2004; 24: Suppl. 48, 714s Year: 2004 The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007 Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 42s Year: 2007 Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2010; 36: 128-134 Year: 2010 COVID-19 and complicated bacterial pneumonia in children Source: ERJ Open Res, 7 (1) 00884-2020; 10.1183/23120541.00884-2020 Year: 2021 Community-acquired pneumonia requiring hospitalization in HIV-infected patients Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Seasonal variation in outcome for hospitalised patients with community-acquired pneumonia Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Signs and symptoms indicative of community-acquired pneumonia in young children in Brazil Source: Eur Respir J 2005; 26: Suppl. 49, 166s Year: 2005 How often can we use short course therapy in patients with hospital-acquired pneumonia? Source: Eur Respir J 2007; 30: Suppl. 51, 408s Year: 2007 Japanese guidelines for the management of community-acquired pneumonia: differential diagnosis of atypical pneumonia and bacterial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 374s Year: 2006 Criteria for clinical stability in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2013; 42: 742-749 Year: 2013